ANI PHARMACEUTICALS, INC (ANIP) Gross margin 2016–2020
ANI PHARMACEUTICALS, INC (ANIP) gross margin by fiscal year — reported gross profit divided by reported revenue.
58.2%FY2020 · since FY2016: 62.1% → 58.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | 58.2% | -11.2 pp |
| FY2019 | 69.4% | +5.7 pp |
| FY2018 | 63.8% | +8.5 pp |
| FY2017 | 55.3% | -6.8 pp |
| FY2016 | 62.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice